Copyright
©The Author(s) 2018.
World J Cardiol. Nov 26, 2018; 10(11): 222-233
Published online Nov 26, 2018. doi: 10.4330/wjc.v10.i11.222
Published online Nov 26, 2018. doi: 10.4330/wjc.v10.i11.222
Table 1 Baseline characteristics of the optical coherence tomography study population
Variable | Overall (n = 64) | OCT-guided PCI (n = 38) | OCT-guided OMT (n = 26) | P-value |
Age (yr) | 63.17 ± 9.68 | 63.42 ± 9.88 | 62.81 ± 9.56 | 0.806 |
Male (%) | 43 (67.2) | 25 (65.8) | 18 (69.2) | 0.773 |
Diabetes mellitus (%) | 10 (15.6) | 7 (18.4) | 3 (11.5) | 0.693 |
Hypertension (%) | 39 (60.9) | 22 (57.9) | 17 (65.4) | 0.546 |
Discharge treatment | ||||
Aspirin (%) | 64 (100) | 38 (100) | 26 (100) | 1 |
P2Y12 inhibitor (%) | 59 (92.2) | 38 (100) | 25 (96.1) | 0.406 |
Statin (%) | 64 (100) | 38 (100) | 26 (100) | 1 |
Beta-blocker (%) | 29 (45.3) | 19 (50) | 10 (38.5) | 0.362 |
ACE-I/ARB (%) | 33 (51.6) | 23 (60.5) | 10 (38.5) | 0.083 |
CCB (%) | 24 (37.5) | 13 (34.2) | 11 (42.3) | 0.511 |
Nitrates (%) | 36 (56.2) | 21 (55.3) | 15 (57.7) | 0.847 |
Admission diagnosis | 0.068 | |||
Stable angina (%) | 7 (10.9) | 4 (10.5) | 3 (11.5) | |
Unstable angina (%) | 53 (82.8) | 34 (89.5) | 19 (73.1) | |
NSTEMI (%) | 2 (3.1) | 0 (0) | 2 (7.7) | |
STEMI (%) | 2 (3.1) | 0 (0) | 2 (7.7) | |
ICL vessel | 0.671 | |||
LAD (%) | 37 (57.8) | 21 (55.3) | 16 (61.5) | |
LCX (%) | 12 (18.8) | 6 (15.8) | 6 (23.1) | |
RCA (%) | 15 (23.4) | 10 (26.3) | 5 (19.2) |
Table 2 Two-dimensional quantitative coronary angiography findings pre-optical coherence tomography in the percutaneous coronary intervention and optimal medical therapy groups
Variable | OCT-guided PCI (n = 38) | OCT-guided OMT (n = 26) | P-value |
Reference area, mm2 | 7.91 (5.61-10.45) | 7.97 (6.01-11.16) | 0.538 |
Minimum luminal area, mm2 | 1.97 (1.37-2.80) | 2.40 (1.73-3.82) | 0.029 |
Area stenosis % | 74.02 ± 6.43 | 67.77 ± 6.44 | 0.001 |
Table 3 Frequency-domain optical coherence tomography findings in the percutaneous coronary intervention and optimal medical therapy groups
Variable | OCT-guided PCI (n = 38) | OCT-guided OMT (n = 26) | P-value |
Reference area mm2 | 9.00 (7.56-11.21) | 9.32 (7.73-12.14) | 0.507 |
Minimum luminal area mm2 | 2.44 (1.93-3.15) | 3.43 (2.61-4.72) | 0.001 |
Area stenosis % | 72.22 ± 7.39 | 61.87 ± 7.51 | < 0.001 |
Table 4 Two-dimensional quantitative coronary angiography vs frequency-domain optical coherence tomography findings
Group | 2D-QCA | FD-OCT | P-value |
Reference area, mm2 | |||
OCT-guided PCI | 8.16 ± 3.24 | 9.39 ± 3.28 | < 0.001 |
OCT-guided OMT | 7.97 (6.01-11.16) | 9.32 (7.73-12.14) | 0.005 |
Minimum luminal area mm2 | |||
OCT-guided PCI | 2.14 ± 1.00 | 2.58 ± 1.04 | < 0.001 |
OCT-guided OMT | 2.40 (1.73-3.82) | 3.43 (2.61- 4.72) | < 0.001 |
Area stenosis % | |||
OCT-guided PCI | 74.02 ± 6.44 | 72.22 ± 7.39 | 0.027 |
OCT-guided OMT | 67.77 ± 7.31 | 61.87 ± 7.51 | < 0.001 |
Table 5 Clinical outcomes at 12 mo follow-up n (%)
Variable | OCT-guided PCI (n = 38) | OCT-guided OMT (n = 26) | P-value, overall = 0.634 |
Myocardial infarction | 1 (2.6) | 0 | 1 |
Target lesion revascularisation | 1 (2.6) | 0 | 1 |
Re-angina | 13 (34.2) | 8 (30.8) | 0.603 |
Re-hospitalisation | 3 (7.9) | 2 (7.7) | 0.920 |
Minor bleeding events | 5 (13.2) | 1 (3.8) | 0.427 |
- Citation: Khurwolah MR, Meng HY, Wang YS, Wang LS, Kong XQ. Safety and efficacy of frequency-domain optical coherence tomography in evaluating and treating intermediate coronary lesions. World J Cardiol 2018; 10(11): 222-233
- URL: https://www.wjgnet.com/1949-8462/full/v10/i11/222.htm
- DOI: https://dx.doi.org/10.4330/wjc.v10.i11.222